B. Kwatra, Rajani Raghavendra, Rutuja Sandip Patre, Dhvani H. Kuntawala
{"title":"Therapeutic enhancement of antibiotics using probiotics: a review","authors":"B. Kwatra, Rajani Raghavendra, Rutuja Sandip Patre, Dhvani H. Kuntawala","doi":"10.18203/2319-2003.ijbcp20212934","DOIUrl":null,"url":null,"abstract":"This article was an examination of the therapeutic enhancement of antibiotics using probiotics. The scientific development and subsequent enhancement of antibiotics continued to influence the researchers all over the globe today. This article examined the research done and published by researchers and scientists. Consideration of current trends and data in scientific queries and demonstrated further aspects of probiotics and antibiotics. Additionally, this article explored options for therapeutic enhancement of ofloxacin, amoxicillin and cefuroxime.","PeriodicalId":13901,"journal":{"name":"International Journal of Basic & Clinical Pharmacology","volume":"3 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2021-07-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Basic & Clinical Pharmacology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.18203/2319-2003.ijbcp20212934","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
This article was an examination of the therapeutic enhancement of antibiotics using probiotics. The scientific development and subsequent enhancement of antibiotics continued to influence the researchers all over the globe today. This article examined the research done and published by researchers and scientists. Consideration of current trends and data in scientific queries and demonstrated further aspects of probiotics and antibiotics. Additionally, this article explored options for therapeutic enhancement of ofloxacin, amoxicillin and cefuroxime.